Characterization of ornithine decarboxylase activies of human breast cancer cells (MCF-7) and spontaneously immortalized human mammary cells (MCF-10).
Authors
Zhu-H; Mathias-PI; Lotz-WG; Savage-RE
Source
Proceedings of the Eighty-Ninth Annual Meeting of the American Association for Cancer Research, March 28 - April 1, 1998, New Orleans, Louisiana. Philadelphia, PA: American Association for Cancer Research, 1998 Mar-Apr; 39:409
Link
NIOSHTIC No.
20027879
Abstract
Epidemiological studies suggest that increased risk of breast cancer is associated with exposures to electromagnetic fields (EMFs). EMFs have been demonstrated to increase Ornithine decarboxylase (ODC) activity in a variety of experimental systems. ODC, the rate limiting enzyme in polyamine synthesis, has been associated with chemical carcinogenesis. Very few if any studies have examined the effects of EMFs on breast cell ODC. Preliminary to our studies of EMF on ODC in human breast cancer cells (MCF-7) and spontaneously immortalized human mammary cells (MCF-10), we attempted to characterize the enzyme's response to a number of common ODC inducers. For the MCF-7 cells, time course studies suggested that ODC activity began to increase at 6 h, peaked at 12 h and then dropped sharply by 24 h. Treatment with 50 nM 12-O-tetradecanoylphorbol-13-acetate (TPA) for 12 h, ODC activity could be induced over 100 folds over the basal level. 9, 10 Dimethyl 1,2 benzanthracene (DMBA) also induced ODC activity of MCF-7 cells in similar manner. In contrast, ODC activity was barely detectable, and was not induced by TPA or DMBA with concentration up to 400 nM in MCF-10A cells. The finding that melatonin, a cytostatic agent induced ODC activity was also peculiar. Melatonin induced ODC activity significantly in MCF-7 cells with 1 nM concentration at 12h. Studies are underway to determine the effects of EMF on the ODC activity of these and other breast cancer cells lines.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.